Blood alterations preceding clinical manifestation of glioblastoma.

被引：0
|
作者：
Ilhan-Mutlu, Aysegul
Wagner, Ludwig
Woehrer, Adelheid
Susanne, Jungwirth
Marosi, Christine
Fischer, Peter
Preusser, Matthias
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Danube Hosp, Dept Psychiat, Vienna, Austria
[3] Med Univ Vienna, Inst Neurol, Vienna, Austria
[4] Med Univ Vienna, Ctr Comprehens Canc, CNS Tumours Unit, Vienna, Austria
[5] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2024
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oncogenic correlates of epilepsy in glioblastoma.
    Berendsen, Sharon
    Spliet, Wim G. M.
    Geurts, Marjolein
    Van Hecke, Wim
    Seute, Tatjana
    Snijders, Tom J.
    Bell, Erica Hlavin
    Chakravarti, Arnab
    Robe, Pierre A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Endostatin antibodies and hyperexpression in glioblastoma.
    David, R
    Valery, N
    Didier, W
    Louis, BA
    Francois, B
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3666S - 3666S
  • [23] IDH1 mutation status and outcome in clinical trials for recurrent glioblastoma.
    Mandel, Jacob Joseph
    Cachia, David
    Liu, Diane D.
    Aldape, Kenneth D.
    Fuller, Greg
    De Groot, John Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Venous thrombotic events in patients with glioblastoma.
    D'Alpium Santos Costa, Diogo D'Agoretta
    Romeira, Daniel
    Valente, Mariana Fernandes
    Passos, Joao
    Esteves, Susana
    Mayer, Alexandra
    Azevedo, Ana
    Marques, Jose Bravo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] A phase Ib/II clinical trial of a novel oxygen therapeutic in chemoradiation of glioblastoma.
    Unger, Evan C.
    Lickliter, Jason D.
    Ruben, Jeremy
    Jennens, Ross
    Kichenadasse, Ganessan
    Gzell, Cecelia
    Mason, Ralph
    Carmody, Raymond
    Becker, Jennifer
    Zhou, Heling
    Sellenger, Michael
    Longacre, Olivia
    Graham, Kaitlin
    Stea, Baldassarre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Clinical trials of VAL-083 in patients with chemo-resistant glioblastoma.
    Bacha, Jeffrey A.
    Steino, Anne
    Schwartz, Richard Stephen
    Langlands, John
    Kanekal, Sarath
    Lopez, Lorena
    O'Brien, Barbara Jane
    Chen, Zhongping
    Penas-Prado, Marta
    Brown, Dennis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Prognostic nomogram in elderly patients with glioblastoma.
    Patel, Mital
    Hashemi-Sadraei, Neda
    Elson, Paul
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Efficacy and safety of selinexor in recurrent glioblastoma.
    Lassman, Andrew B.
    Wen, Patrick Y.
    Van den Bent, Martin J.
    Plotkin, Scott Randall
    Walenkamp, Anna Maria Elisabeth
    Huang, Xiu
    Rodriguez-Lopez, Karla
    Kauffman, Michael G.
    Shacham, Sharon
    Mau-Sorensen, Morten
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] An anatomic proteomic atlas of human glioblastoma.
    Lam, K. H. Brian
    Djuric, Ugljesa
    Batruch, Ihor
    Richer, Maxime
    Diamandis, Phedias
    CANCER RESEARCH, 2021, 81 (13)
  • [30] A NEUROENDOCRINE APPROACH IN THE TREATMENT OF BRAIN GLIOBLASTOMA.
    Porta, E.
    Messina, G.
    Porro, G.
    Lissoni, P.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6118 - 6118
12345